Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity
- PMID: 1688385
- PMCID: PMC249115
- DOI: 10.1128/JVI.64.1.401-405.1990
Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity
Abstract
A recombinant bovine leukemia virus (BLV) was constructed in which the X region was replaced with the bacterial neomycin resistance gene controlled by the simian virus 40 early promoter. This virus, termed BLV-SVNEO, is a self-packaging, activator-dependent retroviral vector. Introduction of the plasmid pBLV-SVNEO into mammalian cells resulted in constitutive expression of the neo gene, whereas the BLV structural genes, gag, pol, and env, were expressed only in the presence of the two regulatory proteins, Tax and Rex. The production and release of recombinant virus by cells transfected with pBLV-SVNEO were proportional to the number of G418-resistant colonies that developed after susceptible cells were exposed to the filtered culture medium. BLV-SVNEO was able to infect cell lines of human, bovine, canine, feline, and murine origin. BLV-producing cell lines were resistant to superinfection with BLV-SVNEO. This cell-virus system should facilitate molecular genetic studies of BLV and will provide a rapid, quantitative measure of BLV infectivity in a variety of cell types. These studies also demonstrate the feasibility of using activator-dependent retroviral vectors such as BLV-SVNEO to deliver foreign genes into cells and eventually animals.
Similar articles
-
Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus.J Virol. 1991 Apr;65(4):1938-45. doi: 10.1128/JVI.65.4.1938-1945.1991. J Virol. 1991. PMID: 1848312 Free PMC article.
-
In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex.J Virol. 1997 Feb;71(2):1514-20. doi: 10.1128/JVI.71.2.1514-1520.1997. J Virol. 1997. PMID: 8995677 Free PMC article.
-
Bovine leukaemia virus packaging cell line for retrovirus-mediated gene transfer.J Gen Virol. 1989 Aug;70 ( Pt 8):1987-93. doi: 10.1099/0022-1317-70-8-1987. J Gen Virol. 1989. PMID: 2549178
-
BLV and HTLV-I: their unique genomic structures and evolutionary relationship.Princess Takamatsu Symp. 1984;15:229-40. Princess Takamatsu Symp. 1984. PMID: 6085845 Review.
-
Epigenetics and leukemia: unraveling oncogenic processes in the BLV ovine model.Front Biosci (Schol Ed). 2009 Jun 1;1(1):154-63. doi: 10.2741/S15. Front Biosci (Schol Ed). 2009. PMID: 19482691 Review.
Cited by
-
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.Retrovirology. 2007 Mar 16;4:18. doi: 10.1186/1742-4690-4-18. Retrovirology. 2007. PMID: 17362524 Free PMC article. Review.
-
CD154 costimulated ovine primary B cells, a cell culture system that supports productive infection by bovine leukemia virus.J Virol. 2001 Feb;75(3):1095-103. doi: 10.1128/JVI.75.3.1095-1103.2001. J Virol. 2001. PMID: 11152482 Free PMC article.
-
Analysis of bovine leukemia virus gag membrane targeting and late domain function.J Virol. 2002 Aug;76(16):8485-93. doi: 10.1128/jvi.76.16.8485-8493.2002. J Virol. 2002. PMID: 12134053 Free PMC article.
-
A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA.EMBO J. 1994 Feb 1;13(3):713-26. doi: 10.1002/j.1460-2075.1994.tb06311.x. EMBO J. 1994. PMID: 8313915 Free PMC article.
-
Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus.J Virol. 1994 Jan;68(1):494-9. doi: 10.1128/JVI.68.1.494-499.1994. J Virol. 1994. PMID: 8254760 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources